10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10

10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10
** Fraud Prevention Notice      Be cautious of scams involving cloned emails and fake phone numbers requesting conference or journal fees. Only make payments via Science Net's official event platform and notify us immediately at [email protected] if you suspect fraud.

Hybrid Event

15th - 16th July 2026 | Oslo, Norway

International Conference on Oncology and Cancer Therapeutics Development (ICOCTD - 26)

Apply to Present Register as Listener
Register for Participation → View available registration categories.
4

Days

4

Hrs

07

Min

02

Sec

Call For Paper

The (ICOCTD) is dedicated to advancing research excellence by bringing together leading scholars, scientists, and professionals from across the globe. It provides a platform for the dissemination of high-quality research and innovative methodologies.

With a strong focus on Oncology, the conference promotes research that contributes to academic depth, practical insights, and interdisciplinary knowledge integration.

Authors are invited to submit papers addressing, but not limited to, the following areas:

01
Emerging cancer therapeutics and treatments
02
Novel drug development in oncology
03
Combination therapies for cancer
04
Immunotherapy advancements in cancer care
05
Targeted therapies in oncology
06
Challenges in cancer drug approval
07
Role of clinical trials in therapeutics
08
Patient access to new treatments
09
Biomarkers in therapeutic decision-making
10
Pharmacogenomics in cancer treatment
11
Cost-effectiveness of cancer therapies
12
Innovations in radiation oncology
13
Palliative care and cancer therapeutics
14
Ethical considerations in drug development
15
Role of technology in cancer therapeutics
16
Long-term outcomes of cancer treatments
17
Global access to cancer therapies
18
Patient adherence to cancer treatment
19
Future trends in cancer therapeutics
20
Collaboration in drug development research

Peer Review Process

All submissions evaluated through structured peer-review to ensure academic rigor. Accepted papers may be considered for high-quality journals.

Registration Details

Secure your participation early. Limited slots are allocated on a first-come, first-served basis.

Publication Opportunities

High-quality submissions prioritized for publication in recognized journals and proceedings.

Submit Your Paper Today Register Early
2026 UPDATE

Consistent Academic Support

Science Net ensures that research activities continue without interruption in the current global situation. Participants can engage through digital and hybrid conference formats.